Skip to main content
Top
Published in: Current Atherosclerosis Reports 12/2013

01-12-2013 | Nutrition (BV Howard, Section Editor)

Flavonoids from Fruit and Vegetables: A Focus on Cardiovascular Risk Factors

Authors: J. Y. Toh, Verena M. H. Tan, Paul C. Y. Lim, S. T. Lim, Mary F. F. Chong

Published in: Current Atherosclerosis Reports | Issue 12/2013

Login to get access

Abstract

Epidemiological studies suggest that high intakes of dietary flavonoids are associated with decreased cardiovascular disease mortality and risk factors. Less is known about the cardioprotective effects of flavonoids from fruit and vegetables. This review summarizes data from studies which examine the effects of commonly consumed fruit and vegetables on cardiovascular disease risk biomarkers in healthy volunteers or at-risk individuals. Although flavonoids from apples, berries, and onions appear to impact positively on blood pressure, vascular function, and serum lipid levels, further research is required to find out the optimal quantity and food matrix for conferring substantial clinical benefit. The benefits from citrus flavonoids are still inconclusive. Further robust, longer-term dietary intervention studies, with the inclusion of placebo or control arms, are required to improve the credibility of the findings and confirm current observations. An improved understanding of the impact of flavonoids from fruit and vegetables can help one make discerning food choices for optimal cardiovascular health.
Literature
1.
go back to reference •• Corcoran MP, McKay DL, Blumberg JB. Flavonoid basics: chemistry, sources, mechanisms of action, and safety. J Nutr Gerontol Geriatr. 2012;31(3):176–89. doi:10.1080/21551197.2012.698219. This article offers comprehensive information on flavonoids, along with details on flavonoid content in various important food sources.PubMedCrossRef •• Corcoran MP, McKay DL, Blumberg JB. Flavonoid basics: chemistry, sources, mechanisms of action, and safety. J Nutr Gerontol Geriatr. 2012;31(3):176–89. doi:10.​1080/​21551197.​2012.​698219. This article offers comprehensive information on flavonoids, along with details on flavonoid content in various important food sources.PubMedCrossRef
2.
go back to reference Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet. 1993;342(8878):1007–11.PubMedCrossRef Hertog MG, Feskens EJ, Hollman PC, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study. Lancet. 1993;342(8878):1007–11.PubMedCrossRef
3.
go back to reference Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr. 2007;85(3):895–909.PubMed Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr. 2007;85(3):895–909.PubMed
6.
go back to reference Kay CD, Hooper L, Kroon PA, et al. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res. 2012;56(11):1605–16. doi:10.1002/mnfr.201200363.PubMedCrossRef Kay CD, Hooper L, Kroon PA, et al. Relative impact of flavonoid composition, dose and structure on vascular function: A systematic review of randomised controlled trials of flavonoid-rich food products. Mol Nutr Food Res. 2012;56(11):1605–16. doi:10.​1002/​mnfr.​201200363.PubMedCrossRef
7.
go back to reference Mulvihill EE, Huff MW. Antiatherogenic properties of flavonoids: Implications for cardiovascular health. Can J Cardiol. 2010;26(A):17A–21A.PubMedCrossRef Mulvihill EE, Huff MW. Antiatherogenic properties of flavonoids: Implications for cardiovascular health. Can J Cardiol. 2010;26(A):17A–21A.PubMedCrossRef
8.
go back to reference El Haouari M, Rosado JA. Modulation of platelet function and signaling by flavonoids. Mini Rev Med Chem. 2011;11(2):131–42.PubMedCrossRef El Haouari M, Rosado JA. Modulation of platelet function and signaling by flavonoids. Mini Rev Med Chem. 2011;11(2):131–42.PubMedCrossRef
9.
go back to reference Siasos G, Tousoulis D, Tsigkou V, et al. Flavonoids in atherosclerosis: An overview of their mechanisms of action. Curr Med Chem. 2013;20(21):2641–60.PubMedCrossRef Siasos G, Tousoulis D, Tsigkou V, et al. Flavonoids in atherosclerosis: An overview of their mechanisms of action. Curr Med Chem. 2013;20(21):2641–60.PubMedCrossRef
11.
go back to reference Heiss C, Schroeter H, Balzer J, et al. Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharmacol. 2006;47(2):S128–35. discussion S72-6.PubMedCrossRef Heiss C, Schroeter H, Balzer J, et al. Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharmacol. 2006;47(2):S128–35. discussion S72-6.PubMedCrossRef
12.
go back to reference Grassi D, Desideri G, Croce G, et al. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des. 2009;15(10):1072–84.PubMedCrossRef Grassi D, Desideri G, Croce G, et al. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des. 2009;15(10):1072–84.PubMedCrossRef
15.
go back to reference Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–38.PubMedCrossRef Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–38.PubMedCrossRef
17.
go back to reference Vita JA, Keaney Jr JF. Endothelial function: A barometer for cardiovascular risk? Circulation. 2002;106(6):640–2.PubMedCrossRef Vita JA, Keaney Jr JF. Endothelial function: A barometer for cardiovascular risk? Circulation. 2002;106(6):640–2.PubMedCrossRef
18.
go back to reference Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: Fruits. J Agric Food Chem. 2001;49(11):5315–21.PubMedCrossRef Vinson JA, Su X, Zubik L, Bose P. Phenol antioxidant quantity and quality in foods: Fruits. J Agric Food Chem. 2001;49(11):5315–21.PubMedCrossRef
19.
go back to reference Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146(3):223–30.PubMedCrossRef Knekt P, Jarvinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146(3):223–30.PubMedCrossRef
21.
go back to reference Auclair S, Chironi G, Milenkovic D, et al. The regular consumption of a polyphenol-rich apple does not influence endothelial function: A randomised double-blind trial in hypercholesterolemic adults. Eur J Clin Nutr. 2010;64(10):1158–65. doi:10.1038/ejcn.2010.135.PubMedCrossRef Auclair S, Chironi G, Milenkovic D, et al. The regular consumption of a polyphenol-rich apple does not influence endothelial function: A randomised double-blind trial in hypercholesterolemic adults. Eur J Clin Nutr. 2010;64(10):1158–65. doi:10.​1038/​ejcn.​2010.​135.PubMedCrossRef
22.
go back to reference Vafa MR, Haghighatjoo E, Shidfar F, et al. Effects of apple consumption on lipid profile of hyperlipidemic and overweight men. Int J Prev Med. 2011;2(2):94–100.PubMed Vafa MR, Haghighatjoo E, Shidfar F, et al. Effects of apple consumption on lipid profile of hyperlipidemic and overweight men. Int J Prev Med. 2011;2(2):94–100.PubMed
23.
go back to reference Nagasako-Akazome Y, Kanda T, Ohtake Y, et al. Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J Oleo Sci. 2007;56(8):417–28.PubMedCrossRef Nagasako-Akazome Y, Kanda T, Ohtake Y, et al. Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index. J Oleo Sci. 2007;56(8):417–28.PubMedCrossRef
24.
go back to reference • Ravn-Haren G, Dragsted LO, Buch-Andersen T, et al. Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers. Eur J Nutr. 2012. doi:10.1007/s00394-012-0489-z. This article looks at the effects of food processing on the flavonoid content of apples and the subsequent effect on CVD risk factors. The results revealed that besides flavonoids, the lack of soluble pectins in clear apple juice as compared with whole apples also had a role to play in improving the lipid profile of the subjects.PubMed • Ravn-Haren G, Dragsted LO, Buch-Andersen T, et al. Intake of whole apples or clear apple juice has contrasting effects on plasma lipids in healthy volunteers. Eur J Nutr. 2012. doi:10.​1007/​s00394-012-0489-z. This article looks at the effects of food processing on the flavonoid content of apples and the subsequent effect on CVD risk factors. The results revealed that besides flavonoids, the lack of soluble pectins in clear apple juice as compared with whole apples also had a role to play in improving the lipid profile of the subjects.PubMed
26.
27.
go back to reference Rizza S, Muniyappa R, Iantorno M, et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(5):E782–92. doi:10.1210/jc.2010-2879.PubMedCrossRef Rizza S, Muniyappa R, Iantorno M, et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(5):E782–92. doi:10.​1210/​jc.​2010-2879.PubMedCrossRef
29.
go back to reference Gorinstein S, Caspi A, Libman I, et al. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem. 2006;54(5):1887–92. doi:10.1021/jf058171g.PubMedCrossRef Gorinstein S, Caspi A, Libman I, et al. Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans. J Agric Food Chem. 2006;54(5):1887–92. doi:10.​1021/​jf058171g.PubMedCrossRef
30.
go back to reference Craig WJ. Phytochemicals: Guardians of our health. J Am Diet Assoc. 1997;97(10 Suppl 2):S199–204.PubMedCrossRef Craig WJ. Phytochemicals: Guardians of our health. J Am Diet Assoc. 1997;97(10 Suppl 2):S199–204.PubMedCrossRef
31.
go back to reference Jung UJ, Kim HJ, Lee JS, et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 2003;22(6):561–8.PubMedCrossRef Jung UJ, Kim HJ, Lee JS, et al. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin Nutr. 2003;22(6):561–8.PubMedCrossRef
32.
35.
go back to reference Erlund I, Koli R, Alfthan G, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87(2):323–31.PubMed Erlund I, Koli R, Alfthan G, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87(2):323–31.PubMed
38.
go back to reference Karlsen A, Retterstol L, Laake P, et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007;137(8):1951–4.PubMed Karlsen A, Retterstol L, Laake P, et al. Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults. J Nutr. 2007;137(8):1951–4.PubMed
40.
go back to reference • Basu A, Fu DX, Wilkinson M, et al. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res. 2010;30(7):462–9. doi:10.1016/j.nutres.2010.06.016. The article discusses several aspects of metabolic syndrome, and provides important findings that support the benefits of strawberries in improving metabolic syndrome.PubMedCrossRef • Basu A, Fu DX, Wilkinson M, et al. Strawberries decrease atherosclerotic markers in subjects with metabolic syndrome. Nutr Res. 2010;30(7):462–9. doi:10.​1016/​j.​nutres.​2010.​06.​016. The article discusses several aspects of metabolic syndrome, and provides important findings that support the benefits of strawberries in improving metabolic syndrome.PubMedCrossRef
43.
go back to reference Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137(11):2405–11.PubMed Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137(11):2405–11.PubMed
44.
go back to reference Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102(7):1065–74. doi:10.1017/S0007114509359127.PubMedCrossRef Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102(7):1065–74. doi:10.​1017/​S000711450935912​7.PubMedCrossRef
45.
go back to reference Loke WM, Hodgson JM, Proudfoot JM, et al. Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88(4):1018–25.PubMed Loke WM, Hodgson JM, Proudfoot JM, et al. Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88(4):1018–25.PubMed
46.
go back to reference Al-Solaiman Y, Jesri A, Mountford W, et al. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24(4):237–46.PubMedCrossRef Al-Solaiman Y, Jesri A, Mountford W, et al. DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. J Hum Hypertens. 2010;24(4):237–46.PubMedCrossRef
47.
go back to reference Long KZ, Santos JI, Rosado JL, et al. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr. 2011;93(3):578–85. doi:10.3945/ajcn.110.003913.PubMedCrossRef Long KZ, Santos JI, Rosado JL, et al. Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections. Am J Clin Nutr. 2011;93(3):578–85. doi:10.​3945/​ajcn.​110.​003913.PubMedCrossRef
48.
go back to reference Latsios G, Tousoulis D, Androulakis E, et al. MicroRNAs in the diagnosis and treatment of unstable angina. Cur Top Med Chem. 2013;13(13):1596–604.CrossRef Latsios G, Tousoulis D, Androulakis E, et al. MicroRNAs in the diagnosis and treatment of unstable angina. Cur Top Med Chem. 2013;13(13):1596–604.CrossRef
49.
go back to reference Tousoulis D, Androulakis E, Papageorgiou N, et al. Novel biomarkers assessing endothelial dysfunction: role of miRNAs. Curr Top Med Chem. 2013;13(13):1518–26.PubMedCrossRef Tousoulis D, Androulakis E, Papageorgiou N, et al. Novel biomarkers assessing endothelial dysfunction: role of miRNAs. Curr Top Med Chem. 2013;13(13):1518–26.PubMedCrossRef
50.
go back to reference Siasos G, Chrysohoou C, Tousoulis D, et al. The impact of physical activity on endothelial function in middle-aged and elderly subjects: The Ikaria study. Hell J Cardiol. 2013;54(2):94–101. Siasos G, Chrysohoou C, Tousoulis D, et al. The impact of physical activity on endothelial function in middle-aged and elderly subjects: The Ikaria study. Hell J Cardiol. 2013;54(2):94–101.
51.
go back to reference Tousoulis D, Siasos G, Zaromitidou M, et al. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int J Cardiol. 2013. doi:10.1016/j.ijcard.2013.01.040. Tousoulis D, Siasos G, Zaromitidou M, et al. The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel. Int J Cardiol. 2013. doi:10.​1016/​j.​ijcard.​2013.​01.​040.
53.
go back to reference Erlund I, Silaste ML, Alfthan G, et al. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002;56(9):891–8. doi:10.1038/sj.ejcn.1601409.PubMedCrossRef Erlund I, Silaste ML, Alfthan G, et al. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Eur J Clin Nutr. 2002;56(9):891–8. doi:10.​1038/​sj.​ejcn.​1601409.PubMedCrossRef
54.
go back to reference Beecher GR. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr. 2003;133(10):3248S–54S.PubMed Beecher GR. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr. 2003;133(10):3248S–54S.PubMed
55.
go back to reference Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38–50.PubMed Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38–50.PubMed
Metadata
Title
Flavonoids from Fruit and Vegetables: A Focus on Cardiovascular Risk Factors
Authors
J. Y. Toh
Verena M. H. Tan
Paul C. Y. Lim
S. T. Lim
Mary F. F. Chong
Publication date
01-12-2013
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 12/2013
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-013-0368-y

Other articles of this Issue 12/2013

Current Atherosclerosis Reports 12/2013 Go to the issue

Genetics (AJ Marian, Section Editor)

Pharmacology of Antiplatelet Agents

Clinical Trials and Their Interpretations (J Plutzky, Section Editor)

Endothelial MicroRNAs and Atherosclerosis

Lipid and Metabolic Effects of Gastrointestinal Surgery (F Rubino, Section Editor)

From Bariatric to Metabolic Surgery: Definition of a New Discipline and Implications for Clinical Practice

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.